drugset / Trial / NCT00302913

Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition

NCT00302913

Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study is a prospective, single-center evaluation of the efficacy of clopidogrel dose adjustment in patients with insufficient platelet inhibition after elective coronary stent implantation.

Timeline

Start
2005-12
Primary completion
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg
Subject Clopidogrel Small molecule 150 mg